<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>OmniSeq Page 5</title>
    <link href="https://fonts.googleapis.com/css?family=Lato&display=swap" rel="stylesheet">

     <link rel="stylesheet" type="text/css" href="/Users/mglynias/Desktop/PycharmProjects/nova/static/css/main.css">
</head>
<body>
<!--
SURGICAL  PATHOLOGY  REVIEW SUMMARY
-->
<img src="/Users/mglynias/Desktop/PycharmProjects/nova/static/IntegratedOncology.jpg" width="150" />

<img class="Omniseq_logo" src="/Users/mglynias/Desktop/PycharmProjects/nova/static/omniseqCdx_logo.png" />

<div class="Section_Header">SURGICAL  PATHOLOGY  REVIEW SUMMARY</div>
<div class="Review_Summary_Wrapper">
    <div>Submitted Pathology Report</div>
    <div>SP20-0000</div>
    <div>Reviewed Pathologic Diagnosis</div>
    <div></div>
    <div></div>
    <div></div>

    <div>Sample Procurement Date</div>
    <div>1/25/20</div>
    <div>Tissue</div>
    <div>Primary Tumor</div>
    <div>Tumor Nuclei</div>
    <div>70%</div>

    <div>Reviewed Pathologic Tissue Site</div>
    <div>Lung</div>
    <div></div>
    <div></div>
    <div></div>
    <div></div>


</div>
<div class="Section_Header">Summary of Received Samples for Testing</div>
<div class="Received_Sample_Header_Wrapper">
    <div>Received</div>
    <div>Sample Label</div>
    <div>Type</div>
    <div>Quantity</div>
    <div>Unit</div>
    <div>Purpose</div>
</div>
<div class="Received_Sample_Wrapper">
    <div>2/20/20</div>
    <div>UHH-20-000000 A0 (AGX20-000000)</div>
    <div>Unstained FFPE Slide</div>
    <div>14</div>
    <div>Slide</div>
    <div>Testing [Controls Adequate]</div>
</div>
<div class="Section_Header">PD-L1  Immunohistochemistry (IHC)</div>
<div class="PD_L1_Immunohistochemistry">
    <strong>Gross Description:</strong> Received from XXXXXXXX Laboratories are a control slide and stained slides labeled
                20-XXXX. These are accompanied by a surgical pathology report and a technical-only procedure report for PD-L1 immunohistochemistry with patientâ€™s name and accession number.
These are submitted for interpretation by OmniSeq pathologists.<br/><br/>
<strong>Regulatory:</strong> PD-L1 IHC 22C3 pharmDx is a qualitative IHC assay that is FDA-approved for in vitro diagnostic use. This test was performed at XXXX Laboratories LLC XXXXXXXXXXXXXXXXX under the direction of XXXXXXXXX, MD Medical Director CLIA# XXXXXXXXX, and interpreted by OmniSeq, Inc. The results of this assay are not intended to be used as the sole means for clinical diagnosis or patient management decisions. The OmniSeq Laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88) and by the New York State Clinical Laboratory Evaluation Program to perform high complexity clinical laboratory testing.

</div>
<div class="Vertical_Spacer_50"></div>
<div class="Vertical_Spacer_50"></div>
<div class="Vertical_Spacer_50"></div>

<div class="Vertical_Spacer_50"></div>
<div class="Footer">
     P-19-01715-150&nbsp;P-20-00000-000 VERSION 1 | Report electronically signed by George Who, MD
    |12/13/2019 10:39 AM ET <br>
    CLIA ID: 33D2098748 | CAP # 9405346 | OmniSeq Inc., 700 Ellicott Street, Buffalo NY 14203 | 1 (800) 781-1259
<img class="Cap_logo" src="/Users/mglynias/Desktop/PycharmProjects/nova/static/cap_logo.png" width="75" />
</div>
</body>
</html>